-
Mashup Score: 0Adjuvant Treatment for Men with Prostate Cancer with High Risk of Metastasis, the ERADICATE Study - Ashley Ross - 1 year(s) ago
In this discussion, Alicia Morgans and Ashley Ross discuss men in the adjuvant setting with the highest risk of prostate cancer metastasis by genomic stratification. They focus their discussion on Decipher molecular testing after prostatectomy and the Phase III ERADICATE study. The ERADICATE trial was presented at this year’s ASCO meeting. Biographies: Ashley Ross, MD, Ph.D., Associate…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0ERADICATE: Ceftobiprole Noninferior to Daptomycin for Complicated Staphylococcus aureus Bacteremia - 2 year(s) ago
The phase 3 study met its primary and secondary end points of all-cause mortality, microbiological eradication rates, and new Staphylococcus aureus bacteremia complications.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#LateBreaking at #IDWeek2022: #Ceftobiprole is noninferior to daptomycin, with or without aztreonam, in adult patients with bacterial bloodstream infections caused by Staphylococcus aureus, #ERADICATE #phase3 @IDWeek2022 https://t.co/8QK0g99l2V
-
-
Mashup Score: 0Adjuvant Treatment for Men with Prostate Cancer with High Risk of Metastasis, the ERADICATE Study - Ashley Ross - 2 year(s) ago
In this discussion, Alicia Morgans and Ashley Ross discuss men in the adjuvant setting with the highest risk of prostate cancer metastasis by genomic stratification. They focus their discussion on Decipher molecular testing after prostatectomy and the Phase III ERADICATE study. The ERADICATE trial was presented at this year’s ASCO meeting. Biographies: Ashley Ross, MD, Ph.D., Associate…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Adjuvant treatment for men with #ProstateCancer with high risk of metastasis. @ashleyrossmdphd @NM_Urology joins @CaPsurvivorship @DanaFarber to discuss the #ERADICATE study in this conversation on UroToday > https://t.co/W7EQo0Ypvq @Decipher_VCYT https://t.co/XYaCMig2yu
-
-
Mashup Score: 0Adjuvant Treatment for Men with Prostate Cancer with High Risk of Metastasis, the ERADICATE Study - Ashley Ross - 2 year(s) ago
In this discussion, Alicia Morgans and Ashley Ross discuss men in the adjuvant setting with the highest risk of prostate cancer metastasis by genomic stratification. They focus their discussion on Decipher molecular testing after prostatectomy and the Phase III ERADICATE study. The ERADICATE trial was presented at this year’s ASCO meeting. Biographies: Ashley Ross, MD, Ph.D., Associate…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Adjuvant treatment for men with #ProstateCancer with high risk of metastasis. @ashleyrossmdphd @NM_Urology joins @CaPsurvivorship @DanaFarber to discuss the #ERADICATE study in this conversation on UroToday > https://t.co/W7EQo1g0U0 @Decipher_VCYT https://t.co/QyUYxmN2re
-
-
Mashup Score: 0Adjuvant Treatment for Men with Prostate Cancer with High Risk of Metastasis, the ERADICATE Study - Ashley Ross - 2 year(s) ago
In this discussion, Alicia Morgans and Ashley Ross discuss men in the adjuvant setting with the highest risk of prostate cancer metastasis by genomic stratification. They focus their discussion on Decipher molecular testing after prostatectomy and the Phase III ERADICATE study. The ERADICATE trial was presented at this year’s ASCO meeting. Biographies: Ashley Ross, MD, Ph.D., Associate…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Adjuvant treatment for men with #ProstateCancer with high risk of metastasis. @ashleyrossmdphd @NM_Urology joins @CaPsurvivorship @DanaFarber to discuss the #ERADICATE study in this conversation on UroToday > https://t.co/W7EQo1gyJy @Decipher_VCYT https://t.co/Pu5e5zn3cM
-
-
Mashup Score: 4
ASCO 2022 ERADICATE, early intervention after radical prostatectomy with ADT with darolutamide versus placebo in men at highest risk of prostate cancer metastasis by genomic stratification, metastatic hormone-sensitive prostate cancer (mHSPC), Decipher molecular testing after prostatectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
A phase III double-blinded study of early intervention after radical prostatectomy with ADT with darolutamide vs PBO in men at highest risk of #ProstateCancer metastasis by genomic stratification #ERADICATE. @CaPsurvivorship > https://t.co/kGAIqb75hf #ASCO22 @zklaassen_md https://t.co/AsNsBNz3To
-
-
Mashup Score: 7
ASCO 2022 ERADICATE, early intervention after radical prostatectomy with ADT with darolutamide versus placebo in men at highest risk of prostate cancer metastasis by genomic stratification, metastatic hormone-sensitive prostate cancer (mHSPC), Decipher molecular testing after prostatectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
A PIII double-blinded study of early intervention after radical prostatectomy with ADT with darolutamide vs PBO in men at highest risk of #ProstateCancer metastasis by genomic stratification #ERADICATE. @CaPsurvivorship @DanaFarber > https://t.co/kGAIqb75hf #ASCO22 @zklaassen_md https://t.co/UU9wM68i4j
-
Adjuvant treatment for men with #ProstateCancer with high risk of metastasis. @ashleyrossmdphd @NM_Urology joins @CaPsurvivorship @DanaFarber to discuss the #ERADICATE study in this conversation on UroToday > https://t.co/W7EQo1g0U0 @Decipher_VCYT https://t.co/l6GZeIap8m